Gaithersburg, MD30+ days ago
The Senior Director, along with the VP, Quality and Compliance Management, will help build and mature the CQA function, oversee vendor and site quality, including audits, and serve as a key partner to Clinical Operations, Regulatory, Pharmacovigilance, Clinical Development, Biostatistics, Data Management, and external partners. The Company's lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD) and alcohol-associated liver disease (ALD).